Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins;Liečba juvenilného pemphigus vulgaris intravenóznymi imunoglobulínmi

Casopis Lekaru Ceskych

Volumn 144, Issue 10, 2005, Pages 700-703

  Szép, Zoltá ^a,b   Danilla, T ^a   Buchvald, D ^a  

^a Kozna Klinika   (Slovakia)

^b NONE   (Slovakia)

Author keywords

Childhood pemphigus; Intravenous immunoglobulins; IVIG; Juvenile pemphigus vulgaris; Therapy

Indexed keywords

AZATHIOPRINE; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; PEMPHIGUS VULGARIS; REMISSION; SIDE EFFECT; DRUG ADMINISTRATION; DRUG COMBINATION; PEMPHIGUS;

ADOLESCENT; AZATHIOPRINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; PEMPHIGUS; PREDNISONE;

EID: 26944483525     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Graff-Lonnevig, V., Kaaman, T.: Juvenile pemphigus vulgaris. Acta Paediatr. Scand., 1991, 80, s. 262-265.
2. Harrington, I., Sneddon, I. B., Walker, A. E.: Pemphigus vulgaris in a 15-year-old girl. Acta Derm. Venerol., 1978, 58, s. 277-279.
3. Engineer, L., Bhol, K. C., Ahmed, A. R.: Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris. J. Am. Acad. Dermatol., 2000, 43, s. 1049-1057.
4. Tappeiner, G., Steiner, A.: High-dose intravenous gammaglobulin: therapeutic failure in pemphigus and pemphigoid. J. Am. Acad. Dermatol., 1989, 20, s. 684-685.
5. Bewley, A. P., Keefe, M.: Succesful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy. Br. J. Dermatol., 1996, 135, s. 128-129.
6. Beckers, R. C. Y., Brand, A., Vermeer, B. J. et al.: Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br. J. Dermatol., 1995, 133, s. 289-293.
7. Harman, K. E., Black, M. M.: High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br. J. Dermatol., 1999, 140, s. 865-874.
8. Mikroverze AISLP, 2000.3 pro MS Windows, Flebogamma® 5% inf. 10g (Institutio Grifols S.A., Barcelona, Spain), příbalová informace - datum poslední revize 07/2000.
9. Imbach, P., Barundun, S., d'Apuzzo, V. et al.: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1981, 1, s. 228-231.
10. Dalakas, M. C.: Intravenous immune globulin therapy for neurologic diseases. Ann. Intern. Med., 1997, 126, s. 721-730.
11. Jolles, S., Hughes, J., Whittaker, S.: Dermatological uses of high-dose intravenous immunoglobulins. Arch. Dermatol., 1998, 134, s. 80-86.
12. Godard, W., Roujeau, J. C., Guillot, B. et al.: Bullous pemphigoid and intravenous gammaglobulin. Ann. Intern. Med., 1985, 103, s. 964-965.
13. Messer, G., Sizmann, N., Feucht, H. et al.: High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. Br. J. Dermatol., 1995, 133, s. 1014-1015.
14. Wever, S., Zillikens, D., Brocker, E.-B.: Succesful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulins as adjuvant therapy. Br. J. Dermatol., 1996, 135, s. 862-863.
15. Colonna, L., Cianchini, F., Frezzolini, A. et al.: Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy? Br. J. Dermatol., 1998, 138, s. 1102-1103.
16. Bystryn, J.-C., Jiao, D., Natow, S.: Treatment of pemphigus with intravenous immunoglobulin, J. Am. Acad. Dermatol., 2002, 47, s. 358-363.
17. Humbert, P., Derancourt, C., Aubin, F. et al.: Effects of intravenous gammaglobulin in pemphigus. J. Am. Acad. Dermatol., 1990, 22, s. 326.
18. Pelacho, B., Natal, C., Espana, A. et al.: Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett., 2004, 21, s. 6-10.
19. Wang, X., Bregegere, F., Frusic-Zlotkin, M. et al.: Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis, 2004, 9, s. 131-143.